echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medicines Company News > Lukang's entry skyrocketed by 180%, and the market of 5 billion urinary system drugs made waves again

    Lukang's entry skyrocketed by 180%, and the market of 5 billion urinary system drugs made waves again

    • Last Update: 2022-03-02
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    A few days ago, the CDE official website showed that the dapoxetine hydrochloride tablets of Suzhou Wangshan Wangshui Biopharmaceuticals | Shandong Lukang Pharmaceutical Group Saite were accepted as imitation 4 types of dapoxetine hydrochloride tablets
    .
    According to data from Minet.
    com, in recent years, China's urban physical pharmacy terminal urinary system chemical drug market has grown steadily.
    It is estimated that the sales in 2021 will be nearly 5 billion yuan, and dapoxetine hydrochloride tablets are TOP5 products
    .
    Entering 2022, good news of Lukang Pharmaceutical will be heard frequently
    .
    The company has successively issued announcements that amoxicillin sodium and clavulanate potassium for injection, penicillin sodium for injection, and tinidazole tablets have been approved and reviewed, and ticagrelor tablets have obtained a drug registration certificate
    .
     
     
    Data show that dapoxetine hydrochloride tablets are selective serotonin reuptake inhibitors (SSRIs) developed by Johnson & Johnson and approved for import in China in 2010 for the treatment of 18-64-year-old male patients with premature ejaculation
    .
     
    According to data from Minet.
    com, in recent years, China's urban physical pharmacy terminal urinary system chemical market has grown steadily.
    It is estimated that the sales in 2021 will be nearly 5 billion yuan, while Dapoxetine hydrochloride tablets are TOP5 products.
    This product will be available in Chinese urban physical pharmacy terminals in 2020.
    It exceeded 70 million yuan, a year-on-year increase of more than 180%.
    It is expected to reach a new high in 2021, with a year-on-year increase of 106.
    43%
    .
    Among them, Germany's Berlin Chemical has the largest market share, Sichuan Kelun Pharmaceutical and Shandong Huabo Triumph Biology occupy the second and third positions respectively
    .
     
      
    Source: One-click retrieval from Minet
     
      At present, 8 companies have production approval documents for dapoxetine hydrochloride tablets.
    Among them, 7 domestic pharmaceutical companies, including Shandong Langnuo Pharmaceutical, Sichuan Kelun Pharmaceutical, Shenzhen Xinlitai Pharmaceutical, have been approved for 4 types of imitations.
    Same review
    .
    In addition, 5 companies including Jiangxi Pharmaceutical and Guangzhou Baiyunshan Pharmaceutical Group Baiyunshan Pharmaceutical General Factory all reported the production of 4 types of imitations in the review and approval process, and will be regarded as over-evaluation after approval .

     
     
      Entering 2022, good news of Lukang Pharmaceutical will be heard frequently
    .
    The company has successively issued announcements stating that amoxicillin sodium and clavulanate potassium for injection, penicillin sodium for injection, and tinidazole tablets have been approved and reviewed, and ticagrelor tablets have obtained a drug registration certificate
    .
      A few days ago, the CDE official website showed that the dapoxetine hydrochloride tablets of Suzhou Wangshan Wangshui Biopharmaceuticals | Shandong Lukang Pharmaceutical Group Saite were accepted as imitation 4 types of dapoxetine hydrochloride tablets
    .
    According to data from Minet.
    com, in recent years, China's urban physical pharmacy terminal urinary system chemical drug market has grown steadily.
    It is estimated that the sales in 2021 will be nearly 5 billion yuan, and dapoxetine hydrochloride tablets are TOP5 products
    .
    Entering 2022, good news of Lukang Pharmaceutical will be heard frequently
    .
    The company has successively issued announcements that amoxicillin sodium and clavulanate potassium for injection, penicillin sodium for injection, and tinidazole tablets have been approved and reviewed, and ticagrelor tablets have obtained a drug registration certificate
    .
     
     
      Data show that dapoxetine hydrochloride tablets are selective serotonin reuptake inhibitors (SSRIs) developed by Johnson & Johnson and approved for import in China in 2010 for the treatment of 18-64-year-old male patients with premature ejaculation
    .
     
      According to data from Minet.
    com, in recent years, China's urban physical pharmacy terminal urinary system chemical market has grown steadily.
    It is estimated that the sales in 2021 will be nearly 5 billion yuan, while Dapoxetine hydrochloride tablets are TOP5 products.
    This product will be available in Chinese urban physical pharmacy terminals in 2020.
    It exceeded 70 million yuan, a year-on-year increase of more than 180%.
    It is expected to reach a new high in 2021, with a year-on-year increase of 106.
    43%
    .
    Among them, Germany's Berlin Chemical has the largest market share, Sichuan Kelun Pharmaceutical and Shandong Huabo Triumph Biology occupy the second and third positions respectively
    .
     
      
    Source: One-click retrieval from Minet
     
      At present, 8 companies have production approval documents for dapoxetine hydrochloride tablets.
    Among them, 7 domestic pharmaceutical companies, including Shandong Langnuo Pharmaceutical, Sichuan Kelun Pharmaceutical, Shenzhen Xinlitai Pharmaceutical, have been approved for 4 types of imitations.
    Same review
    .
    In addition, 5 companies including Jiangxi Pharmaceutical and Guangzhou Baiyunshan Pharmaceutical Group Baiyunshan Pharmaceutical General Factory all reported the production of 4 types of imitations in the review and approval process, and will be regarded as over-evaluation after approval .

     
     
      Entering 2022, good news of Lukang Pharmaceutical will be heard frequently
    .
    The company has successively issued announcements stating that amoxicillin sodium and clavulanate potassium for injection, penicillin sodium for injection, and tinidazole tablets have been approved and reviewed, and ticagrelor tablets have obtained a drug registration certificate
    .
      A few days ago, the CDE official website showed that the dapoxetine hydrochloride tablets of Suzhou Wangshan Wangshui Biopharmaceuticals | Shandong Lukang Pharmaceutical Group Saite were accepted as imitation 4 types of dapoxetine hydrochloride tablets
    .
    According to data from Minet.
    com, in recent years, China's urban physical pharmacy terminal urinary system chemical drug market has grown steadily.
    It is estimated that the sales in 2021 will be nearly 5 billion yuan, and dapoxetine hydrochloride tablets are TOP5 products
    .
    Entering 2022, good news of Lukang Pharmaceutical will be heard frequently
    .
    The company has successively issued announcements that amoxicillin sodium and clavulanate potassium for injection, penicillin sodium for injection, and tinidazole tablets have been approved and reviewed, and ticagrelor tablets have obtained a drug registration certificate
    .
     
     
      Data show that dapoxetine hydrochloride tablets are selective serotonin reuptake inhibitors (SSRIs) developed by Johnson & Johnson and approved for import in China in 2010 for the treatment of 18-64-year-old male patients with premature ejaculation
    .
    male male male
     
      According to data from Minet.
    com, in recent years, China's urban physical pharmacy terminal urinary system chemical market has grown steadily.
    It is estimated that the sales in 2021 will be nearly 5 billion yuan, while Dapoxetine hydrochloride tablets are TOP5 products.
    This product will be available in Chinese urban physical pharmacy terminals in 2020.
    It exceeded 70 million yuan, a year-on-year increase of more than 180%.
    It is expected to reach a new high in 2021, with a year-on-year increase of 106.
    43%
    .
    Among them, Germany's Berlin Chemical has the largest market share, Sichuan Kelun Pharmaceutical and Shandong Huabo Triumph Biology occupy the second and third positions respectively
    .
    pharmacy pharmacy pharmacy
     
      
    Source: One-click retrieval from Minet
     
      At present, 8 companies have production approval documents for dapoxetine hydrochloride tablets.
    Among them, 7 domestic pharmaceutical companies, including Shandong Langnuo Pharmaceutical, Sichuan Kelun Pharmaceutical, Shenzhen Xinlitai Pharmaceutical, have been approved for 4 types of imitations.
    Same review
    .
    In addition, 5 companies including Jiangxi Pharmaceutical and Guangzhou Baiyunshan Pharmaceutical Group Baiyunshan Pharmaceutical General Factory all reported the production of 4 types of imitations in the review and approval process, and will be regarded as over-evaluation after approval .

    Pharmaceutical pharmaceutical pharmaceutical enterprise enterprise enterprise
     
     
      Entering 2022, good news of Lukang Pharmaceutical will be heard frequently
    .
    The company has successively issued announcements stating that amoxicillin sodium and clavulanate potassium for injection, penicillin sodium for injection, and tinidazole tablets have been approved and reviewed, and ticagrelor tablets have obtained a drug registration certificate
    .
    medicines medicines medicines
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.